The U.S. Food and Drug Administration (FDA) said it is aware that Boston Scientific Corporation (NYSE: BSX) has alerted customers to remove certain AXIOS stents and electrocautery-enhanced delivery ...

Add Yahoo as a preferred source to see more of our stories on Google. Boston Scientific's headquarters is in Marlborough, Massachusetts. (Courtesy of Boston Scientific) This story was originally ...

Boston Scientific (NYSE:BSX) is facing multiple new securities class action lawsuits tied to disappointing earnings, lowered sales guidance, and a Class I recall of its AXIOS Stent and Delivery ...

FDA flags safety risk with Boston Scientific stents after reports of deployment issues causing deaths and injuries, prompting a Class I recall.

Boston Scientific Corp BSX on Wednesday initiated the removal of certain AXIOS Stents and Electrocautery-Enhanced Delivery Systems from clinical settings following reports of deployment complications ...

Boston Scientific is running a clinical study titled “A Prospective Multi-Center, Single-Arm Study of Endoscopic Ultrasound-Guided Gastroenterostomy With Lumen-Apposing Metal Stent for Gastric Outlet ...

Xlumena, Inc., a leader in the development of advanced endoscopic devices, today announced the close of a $25 million Series C financing. Led by Third Point LLC, the round of funding includes existing ...

Marlborough-based medical device manufacturer Boston Scientific has reached an agreement to acquire Xlumena Inc. Based in Mountain View, Calif., Xlumena makes minimally invasive devices to drain ...